IL-33/PIBF1信号通路异常抑制子宫内膜间质细胞蜕膜化导致胚胎反复种植失败的机制
批准号:
82071712
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
徐步芳
依托单位:
学科分类:
辅助生殖
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
徐步芳
中文摘要
子宫内膜间质细胞(HESC)蜕膜化缺陷是导致胚胎反复种植失败(RIF)的关键因素。前期研究发现:HESC中PIBF1/IL-6低表达抑制细胞增殖及蜕膜化;RIF患者分泌中期IL-33水平显著降低,与PIBF1一致;敲低T-HESC及HESC中IL-33后PIBF1、IL-6及增殖与蜕膜化的标志物表达均降低,并可逆转;而敲低其受体ST2L,PIBF1及IL-6表达亦降低,过表达IL-33后不能恢复;IL-33条件敲除小鼠动情期子宫内膜以上因子表达均低下。由此推测,低水平的IL-33通过PIBF1/IL-6信号通路抑制子宫内膜间质细胞增殖和蜕膜化进而影响子宫内膜容受性。本项目拟系统研究IL-33等分子标志物与RIF的相关性;明晰IL-33调控蜕膜化的作用;揭示IL-33/ST2调控PIBF1信号通路诱导HESC增殖及蜕膜化的机制;探索以干预IL-33相关信号通路为核心防治胚胎种植失败的新策略。
英文摘要
Defective decidualization of the human endometrial stromal cell (HESC) is the crux of recurrent implantation failure (RIF). Our preliminary results showed that the inferior expression of PIBF1/IL-6 in mid-secretory HESC in RIF patients results in suppressed cell proliferation, which is closely related to defective decidualization. The level of IL-33 in the RIF patients, which is the same as that of PIBF1, was down-regulated as well. Knockdown the expression of IL-33, the expression of PIBF1, IL-6 and the markers of HESC proliferation and decidualization would decrease but could be rescued. Knockdown the expression of its receptor, ST2L, the expression of PIBF1, IL-6 was decreased as well and forced expression of IL-33 could not rescue the expression of PIBF1 and IL-6. What’s more, the expression of PIBF1, IL-6 and markers of HESC decidualization was down-regulated in the endometrium of IL-33 cKO mice during the estrus. The scientific issue focused on in this project is the mechanism by which abnormal IL-33/PIBF1 signaling pathway inhibits the decidualization of endometrial stromal cells, thus causes recurrent implantation failure. We are about to systematically clarify the correlation between RIF and the potential markers like IL-33 and PIBF1.etc, to elucidate the role and the mechanism of IL-33/ST2 in regulating HESC proliferation and the following decidualization via regulating PIBF1 signaling pathway, to investigate and formulate a new strategy to prevent the failure of embryo implantation by interfering IL-33 related signaling pathways.
胚胎反复着床失败(RIF)是体外受精-胚胎移植(IVF-ET)中亟待解决的临床难题。该问题主要与子宫内膜的低容受性有关,其复杂的病理机制至今未被完全揭示。本研究深入探讨了子宫内膜容受性的分子基础,证实了PIBF1通过调控IL6/p-STAT3信号通路调控子宫内膜间质细胞增殖,并引起间质细胞蜕膜化功能改变,影响子宫内膜容受性。进一步研究发现,CD44v3、IFN-γ/SEPT11和LEF1活性的变化会影响子宫内膜黏附、迁移、增殖、蜕膜化和免疫调控过程,这些变化共同导致子宫内膜容受性的异常,从而抑制胚胎的正常着床。此外,本研究成功开发的脂肪脱细胞活性蛋白复合水凝胶材料显示出促进子宫内膜修复和提高其容受性的潜力。本项工作不仅深化了我们对子宫内膜容受性发病机制的理解,而且聚焦于其影响因素的临床难题,注重多学科交叉合作的研究方法。我们的发现为RIF患者寻找新的分子标志物和治疗靶点提供了宝贵的科学依据,为提高IVF的妊娠成功率开辟了新的策略和视角。
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
Tim-3信号通路异常调控uNK细胞分泌perforin影响反复着床失败患者子宫内膜容受性的分子机制
-
批准号:81771656
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:徐步芳
-
依托单位:
LIF-JAK/STAT3信号转导通路在慢性子宫内膜缺血所致反复着床失败中的作用机制
-
批准号:81300548
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:徐步芳
-
依托单位:
国内基金
海外基金